AstraZeneca plc's (NASDAQ: AZN) vaccine head highlighted the confidence that the company's new COVID-19 antibody treatment could protect immunocompromised patients against all known virus variants.
Johnson & Johnson's (NYSE: JNJ) subsidiary, LTL Management, has reportedly requested a U.S. judge to delay 38,000 lawsuits again. These lawsuits accuse their baby powder and other talc products of causing cancer.
On Tuesday, the FDA amended the emergency use authorizations (EUAs) of Moderna Inc (NASDAQ:MRNA) and Pfizer Inc (NYSE:PFE), and BioNTech SE’s (NASDAQ:BNTX) COVID-19 bivalent mRNA vaccines…
Life-sciences company Danaher Corporation (NYSE:DHR) is reportedly no longer considering a takeover of contract manufacturer Catalent Inc (NYSE:CTLT) after expressing interest in…
Bank of America (NYSE: BAC) outperforms expectations for the first quarter financial results, delivering a 16% positive surprise in earnings per share ($0.94 vs.